CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (33.33%)
Mar 24, 2026, 3:34 PM EST
CBD Life Sciences Revenue
CBD Life Sciences had revenue of $42.85K in the quarter ending March 31, 2024, with 92.00% growth. This brings the company's revenue in the last twelve months to $178.45K, up 29.13% year-over-year. In the year 2023, CBD Life Sciences had annual revenue of $167.15K with 4.31% growth.
Revenue (ttm)
178.45K
Revenue Growth
+29.13%
P/S Ratio
6.39
Revenue / Employee
44.61K
Employees
5
Market Cap
1.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 167.15K | 6.91K | 4.31% |
| Dec 31, 2022 | 160.24K | 76.86K | 92.17% |
| Dec 31, 2021 | 83.39K | -142.51K | -63.09% |
| Dec 31, 2020 | 225.90K | 146.26K | 183.67% |
| Dec 31, 2019 | 79.64K | -448.37K | -84.92% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tian'an Pharmaceutical | 10.65M |
| Global Roundtable | 1.24M |
| Opus Holdings | 758.68K |
| LiveWire Ergogenics | 571.68K |
| Nutra Pharma | 429.86K |
| TransGlobal Assets | 91.35K |
| Branded Legacy | 87.65K |
| Grapefruit USA | 34.85K |